Prof. Dr. NESLİHAN CABIOĞLU

ATLAS Yayın Analitiği

Makaleler 164

1. The Schrödinger's Cat Paradox: Can MAMMI PET with ⁶⁸Ga-FAPI Determine Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Omitting Surgery?

OFLAS M., HAS ŞİMŞEK D., YILMAZ R. S., CABIOĞLU N., ÖNDER S., IŞIK E. G., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.41, sa.5, ss.410-419, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study

Montagna G., Alvarado M., Myers S., Mrdutt M. M., Sun S. X., Sevilimedu V., et al.

LANCET ONCOLOGY , cilt.27, sa.1, ss.57-67, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye

Karadeniz Cakmak G., Tali U., Balbaloglu H., Tasdoven I., Ozkurt E., KARANLIK H., et al.

European journal of public health , cilt.35, sa.6, ss.1271-1280, 2025 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

4. Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry Study

Cabıoğlu N., Türkyılmaz Z., Özkurt E., İğci A., Müslümanoğlu M., Kapkaç M., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.26, sa.12, ss.4407-4417, 2025 (Scopus)

5. Long-term outcomes of Türkiye's first population-based mammography screening program: a decade of breast cancer detection and survival analysis in Bahçeşehir

ÖZÇINAR B., ARIBAL M. E., Cabioglu N., Gurdal S. O., Varol G., AKYURT N., et al.

BMC WOMENS HEALTH , cilt.25, sa.1, 2025 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

6. Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Soran A., Göktepe B., Demirors B., Aytac O., Ozbas S., Dogan L., et al.

Current Oncology , cilt.32, sa.10, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Air-Assisted Mastectomy Using LigaSure for a Breast Cancer Patient With a Cardiac Pacemaker

Tukenmez M., Mollavelioglu B., Emiroglu S., Cabioglu N., Muslumanoglu M., Ozmen V.

European Journal of Breast Health , cilt.21, sa.4, ss.384-386, 2025 (ESCI, Scopus, TRDizin)

8. Comparison of tumor clipping and marking of skin projection methods in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy: A randomized controlled trial

Kut A., EMİROĞLU S., CABIOĞLU N., Muslumanoglu M., Yilmaz R. S., Bozdogan A., et al.

MEDICINE , cilt.104, sa.36, 2025 (SCI-Expanded, Scopus)

9. Curcumin as an Epigenetic Modulator: Suppression of Breast Cancer via the Hsa_circ_0001946/MiR-7-5p/Target Gene Axis

Abuaisha A., Kaya M., Suer İ., Emiroglu S., Bayram A., Tukenmez M., et al.

MEDICINA-LITHUANIA , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Breast Cancer Awareness Related to Screening in a General Population of Turkish Women

AKYURT N., ARIBAL M. E., Cabioglu N., ÖZÇINAR B., Ozkan Gurdal S., Ozmen V.

Asian Pacific Journal of Cancer Prevention , cilt.26, sa.9, ss.3389-3398, 2025 (Scopus)

11. Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

Cabıoğlu N., Karanlık H., Iğci A., Müslümanoğlu M., Gürsoy O. M., Tükenmez M., et al.

Journal of breast cancer , 2025 (SCI-Expanded, Scopus)

12. An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients

Weiss A., Agnese D. M., Al-Hilli Z., CABIOĞLU N., Farr D., Kantor O., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.8, ss.5453-5466, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification

Emiroglu M., ÇETİN K., Yilmaz K. B., VELİDEDEOĞLU M., Girgin S., Akcan A., et al.

Breast Care , cilt.20, sa.4, ss.248-255, 2025 (SCI-Expanded, Scopus)

14. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

Cabıoğlu N., KARANLIK H., Özmen V., Tükenmez M., İğci A., Aytin Y. E., et al.

Clinical Breast Cancer , cilt.25, sa.5, ss.455-463, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring

Quiambao A., Malekpour M., Golestani A., Heidari-Foroozan M., Ghamari S., Abbasi-Kangevari M., et al.

eClinicalMedicine , cilt.85, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.

Cabıoğlu N., Ercan D. O., Karataş İ., Eröz E., Toprak S., Emiroğlu S., et al.

Langenbeck's archives of surgery , cilt.410, sa.1, ss.196, 2025 (SCI-Expanded, Scopus)

17. Role of Lymphoscintigraphy in Repeat Sentinel Lymph Node Biopsy for cN0 Ipsilateral Breast Cancer Recurrence.

Dinçer B., Has Şimşek D., Emiroğlu S., Tükenmez M., Müslümanoğlu M., Cabıoğlu N.

Molecular imaging and radionuclide therapy , cilt.34, sa.2, ss.122-128, 2025 (ESCI, TRDizin) Sürdürülebilir Kalkınma

18. Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Cabıoğlu N., KARANLIK H., İğci A., URAS C., DÜLGEROĞLU O., Karadeniz Çakmak G., et al.

EJSO , cilt.51, sa.6, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

Sanli A. N., KARA H., Tekcan Sanli D. E., ARIKAN A. E., Cabioglu N., URAS C.

World Journal of Surgery , cilt.49, sa.6, ss.1406-1417, 2025 (SCI-Expanded, Scopus)

20. Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study

Cabioglu N., KARANLIK H., Ozmen V., TÜKENMEZ M., Igci A., AYTİN Y. E., et al.

CLINICAL CANCER RESEARCH , cilt.31, sa.12, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

CABIOĞLU N., Kocer H. B., KARANLIK H., Guelcelik M. A., Igci A., Muesluemanoglu M., et al.

JAMA SURGERY , cilt.160, sa.3, ss.257-266, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study

Montagna G., Laws A., Ferrucci M., Mrdutt M. M., Sun S. X., BADEMLER S., et al.

Journal of Clinical Oncology , cilt.43, sa.7, ss.810-820, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

CABIOĞLU N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

24. ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered

Cabioglu N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.971-972, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

Cabioglu N., Karanlık H., Igci A., Muslumanoglu M., Gulcelik M. A., Uras C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.952-966, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Estrogen receptor positivity in stromal cells of the tumor bed predicts the response to neoadjuvant chemotherapy for breast carcinoma

BAYRAM A., Bagbudar S., KARANLIK H., CABIOĞLU N., AYDINER A., ÖNDER S., et al.

BREAST CANCER RESEARCH AND TREATMENT , 2025 (SCI-Expanded, Scopus)

27. Evaluating the efficacy of preoperative radiotherapy in breast cancer patients non-responsive to neoadjuvant chemotherapy: A clinical trial

Muslumanoglu M., Ozkurt E., EMİROĞLU S., İBİŞ K., Abuaisha A., TÜKENMEZ M., et al.

BIOMEDICAL RESEARCH AND THERAPY , sa.12, ss.6978-6988, 2025 (ESCI) Sürdürülebilir Kalkınma

28. Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

Muslumanoglu M., Cabioglu N., Igci A., Karanlık H., Kocer H. B., Senol K., et al.

CANCER , cilt.131, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Abbreviated MRI Screening in Turkish Women Aged 40-69 With Dense Breasts: A Prospective Feasibility Study

KIZILDAĞ YIRGIN İ., Cabioglu N., Dursun M., Can Tasci O., Şener A., Vatandaş G., et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , cilt.24, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabıoğlu N., KARANLIK H., Yılmaz R. S., Emiroğlu S., Tükenmez M., BADEMLER S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy

Muslumanoglu M., Mollavelioglu B., Cabioglu N., Emiroglu S., Tukenmez M., Karanlık H., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report

Emiroglu M., Akcan A., VELİDEDEOĞLU M., Girgin S., Aytac O., CANTÜRK N. Z., et al.

Breast Care , cilt.19, sa.5, ss.243-251, 2024 (SCI-Expanded, Scopus)

33. Diagnostic capabilities of artificial intelligence as an additional reader in a breast cancer screening program

Seker M. E., Koyluoglu Y. O., ÖZAYDIN A. N., Gurdal S. O., ÖZÇINAR B., Cabioglu N., et al.

EUROPEAN RADIOLOGY , cilt.34, sa.9, ss.6145-6157, 2024 (SCI-Expanded, Scopus)

34. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer

Cabioglu N., Onder S., Karatay H., Bayram A., Oner G., Tukenmez M., et al.

Cancers , cilt.16, sa.13, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

Montagna G., Mrdutt M. M., Sun S. X., Hlavin C., Diego E. J., Wong S. M., et al.

JAMA Oncology , cilt.10, sa.6, ss.793-798, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET).

Banys-Paluchowski M., Kuehn T., Masannat Y., Ditsch N., Cabıoğlu N., Harvey J., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.42, sa.16_suppl, ss.67-68, 2024 (Scopus)

37. A Novel Surgical Technique for Gynecomastia: Air-Assisted Minimally Invasive Surgery With Single Axillary Incision

Tukenmez M., Mollavelioglu B., Kozanoglu E., Emiroglu S., Cabioglu N., Muslumanoglu M.

SURGICAL INNOVATION , cilt.31, sa.1, ss.5-10, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience

Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.

Turk Onkoloji Dergisi , cilt.39, sa.3, ss.257-264, 2024 (ESCI, Scopus, TRDizin)

39. Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.

Bagbudar S., KARANLIK H., Cabioglu N., Bayram A., Tükenmez M., AYDINER A., et al.

Medical oncology (Northwood, London, England) , cilt.41, sa.1, ss.18, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.

Journal of Cancer Research and Clinical Oncology , cilt.149, sa.16, ss.14833-14841, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Pregnancy-associated breast malignancy mostly presents with an aggressive type of breast cancer

ACAR İ., Ercan L. D., EMİROĞLU S., TÜKENMEZ M., EMİROĞLU B., Muslumanoglu M., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , sa.5, ss.1-10, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Effect of Cold Therapy on Managing Postoperative Pain Following Breast Conserving Surgery

Emiroglu S., Esen E., Yalcin N., Azizoglu F. S., Zent N., Bozdogan A., et al.

PAIN MANAGEMENT NURSING , cilt.24, sa.4, ss.452-455, 2023 (SCI-Expanded, SSCI) Sürdürülebilir Kalkınma

43. Pure Tubular Breast Carcinoma: Clinicopathological Characteristics and Clinical Outcomes

Emiroglu S., Abuaisha A. M., Tukenmez M., Cabioglu N., Bayram A., Ozmen V., et al.

European Journal of Breast Health , cilt.19, sa.2, ss.115-120, 2023 (Scopus, TRDizin)

44. Evaluation of Benign Breast Diseases with or without Atypical Epithelial Hyperplasia Accompanying Radial Scars

Turkyilmaz Z., Sarisik E., Ozkurt E., Tukenmez M., Emiroglu S., Emiroglu B., et al.

European Journal of Breast Health , cilt.19, sa.2, ss.166-171, 2023 (Scopus, TRDizin)

45. Single axillary incision endoscopic surgery and liposuction for gynecomastia

Tukenmez M., Emiroglu S., Kozanoglu E., Akalin B. E., Mollavelioglu B., Cabioglu N., et al.

Medicine (United States) , cilt.102, sa.7, 2023 (SCI-Expanded, Scopus)

46. Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)

Banys-Paluchowski M., Kühn T., Masannat Y., Rubio I., de Boniface J., Ditsch N., et al.

Cancers , cilt.15, sa.4, 2023 (SCI-Expanded, Scopus)

47. Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?

Emiroglu S., Özkurt E., Cabıoglu N., Igci A., Saip P., YAZICI H., et al.

Breast Cancer: Targets and Therapy , cilt.15, ss.163-173, 2023 (SCI-Expanded, Scopus)

48. Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approach

Cabioglu N., Aktas E., Emiroglu S., Tukenmez M., Ozkurt E., Muslumanoglu M., et al.

CELL BIOLOGY INTERNATIONAL , cilt.47, sa.1, ss.228-237, 2023 (SCI-Expanded, Scopus)

49. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

CABIOĞLU N., BAYRAM A., EMİROĞLU S., ÖNDER S., Karatay H., Oner G., et al.

FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded, Scopus)

50. Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis

Cabioglu N., Trabulus D. C., Emiroglu S., Ozkurt E., Yalcin N., Dinc N., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded, Scopus)

51. Surgery for phyllodes tumour of the breast. What should be surgical margins?

Tukenmez M., Mollavelioglu B., Onder S., Emiroglu S., VELİDEDEOĞLU M., ERGÜN S., et al.

ANZ Journal of Surgery , cilt.93, sa.1-2, ss.257-262, 2023 (SCI-Expanded, Scopus)

52. Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy

Cabioglu N., URAS C., Mutlu H., Sezgin D., Emiroglu S., DÜLGEROĞLU O., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded, Scopus)

53. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes

Özkurt E., Emiroğlu S., Cabioğlu N., Karanlık H., Önder S., Tükenmez M., et al.

BREAST CARE , cilt.17, sa.6, ss.554-560, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

URAS C., Cabioglu N., TOKAT F., ER O., KARA H., KORKMAZ T., et al.

BMC Cancer , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

55. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer

Has Simsek D., Emiroglu S., Yilmaz R. S., Bayram A., Isik E. G., Tukenmez M., et al.

CLINICAL NUCLEAR MEDICINE , cilt.47, sa.11, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer

MOLLAVELİOĞLU B., ÇETİN E., CABIOĞLU N., Abbasov A., ÖNDER S., EMİROĞLU S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.20, sa.1, 2022 (SCI-Expanded, Scopus)

57. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes

EMİROĞLU S., Tukenmez M., Karakus S., KARANLIK H., Onder S., Ozmen V., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.18, sa.4, ss.353-359, 2022 (ESCI, Scopus, TRDizin)

58. Can We Predict Triple Negative Breast Cancer with Magnetic Resonance Imaging Findings?

CİNGÖZ E., CÖMERT R. G., BAYRAMOĞLU Z., CABIOĞLU N., Yılmaz S. R.

Current Research in MRI , cilt.1, sa.2, ss.33-37, 2022 (TRDizin)

59. Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study

Yirgin İ., Engin G., Yildiz Ş., Aydin E. C., Karanlik H., Cabioglu N., et al.

CURRENT MEDICAL IMAGING , cilt.18, sa.10, ss.1052-1060, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. The Contribution of ¹⁸F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer

Oflas M., Simsek D. H., Isik E., Cabioglu N., Ibis K., Aydiner A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

61. Sentinel lymph node biopsy with/without axillary dissection in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabioglu N., Karanlik H., Gulcelik M. A., Ilgun S., Igci A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.69-70, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

62. The American Society of Breast Surgeons Official Proceedings, Volume XXIII 2022 Annual Meeting Scientific Session Abstracts

Müslümanoğlu M., Özkurt S., Emiroğlu S., Özkurt E., Küçücük S., Tükenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.S1, ss.288, 2022 (SCI-Expanded, Scopus)

63. Efficacy of preoperative radiotherapy for non-responder breast cancer patients following to neoadjuvant chemotherapy

Muslumanoglu M., Emiroglu S., Ozkurt E., Ozkurt S., Kucucuk S., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.288, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Topografic localisation is enough for correct excision following neoadjuvant chemotherapy in nonpalpable breast cancer

Muslumanoglu M., Emiroglu S., Mollavelioglu B., Atalay B., Yanik M., Yilmaz R., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.171, 2022 (SCI-Expanded, Scopus)

65. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Tukenmez M., Emiroglu S., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.310-311, 2022 (SCI-Expanded, Scopus)

66. Poor Outcome in Pregnancy-associated Breast Cancer among Turkish Women:An aggressive type of breast carcinoma

Acar I., Yıldırım D. O., Emiroğlu S., Tükenmez M., Müslümanoğlu M., İğci A., et al.

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , cilt.48, sa.2, ss.57, 2022 (Scopus)

67. Prognostic Implications of Immune Infiltrates in the Breast Cancer Microenvironment: The Role of Expressions of CTLA-4, PD-1, and LAG-3

Bagbudar S., Karanlik H., Cabioglu N., Bayram A., Ibis K., Aydin E., et al.

Applied Immunohistochemistry and Molecular Morphology , cilt.30, sa.2, ss.99-107, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis

KIZILDAĞ YIRGIN İ., Koyluoglu Y. O., Seker M. E., Ozkan Gurdal S., ÖZAYDIN A. N., Ozcinar B., et al.

Technology in Cancer Research and Treatment , cilt.21, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

Cabıoğlu N., Karanlık H., Yıldırım N., Müslümanoğlu M., Çakmak Karadeniz G., Trabulus Can D., et al.

EJSO , sa.10, ss.2506-2514, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment

Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.

BREAST CARE , cilt.16, sa.5, ss.468-474, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. NEUROENDOCRINE CARCINOMA OF THE BREAST: 18 CASES WITH LONG-TERM FOLLOW-UP

Ozkurt E., İLHAN M., Cucuk O. C., TÜKENMEZ M., CABIOĞLU N., Muslumanoglu M.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.84, sa.4, ss.521-525, 2021 (ESCI, TRDizin)

72. The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study

Soran A., Dogan L., Isik A., Ozbas S., Trabulus D. C., Demirci U., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.9, ss.5048-5057, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.19, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q

Soran A., Soyder A., Ozbas S., Ozmen V., Karanlik H., Igci A., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.7, ss.3823-3830, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Is Sentinel Lymph Node Biopsy with Radiotherapy Alone Safe in Clinically Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?: Turkish Multicentric Neosentiturk-Trial/MF-18-03

Cabioglu N., Karanlik H., Muslumanoglu M., Ozmen V., Karadeniz G., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.SUPPL 2, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

76. Efficacy of Ozone Therapy as a Novel Potential Therapeutic Approach in Severe Granulomatous Mastitis

Cabioglu N., Trablus D. C., Yalcin N., Emiroglu S., Dinc N., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, 2021 (SCI-Expanded, Scopus)

77. Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.

Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.15, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Ozone Therapy as a Novel Potential Approach in Patients with Severe Granulomatous Mastitis Is Associated with an Improved T-helper-1 Response

Cabioglu N., Aktas E., Emiroglu S., Tukenmez M., Dinc N., Muslumanoglu M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, 2021 (SCI-Expanded, Scopus)

79. Is There Any Advantage of Targeted Axillary Dissection After Neoadjuvant Chemotherapy in Patients with Initially Positive Clipped Node?

Cabioglu N., Karanlik H., Yilmaz R., Emiroglu S., Dursun M., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.SUPPL 2, 2021 (SCI-Expanded, Scopus)

80. The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study

Soran A., Dogan L., Ozbas S., Isik A., Trablus D., Demirci U., et al.

BREAST , cilt.56, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

81. TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

BMC CANCER , cilt.21, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

82. Bahcesehir long-term population-based screening compared to National Breast Cancer Registry Data: effectiveness of screening in an emerging country

Gurdal S. O., Özaydın A. N., Arıbal M. E., Özçınar B., Cabıoğlu N., Sahin C., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.27, sa.2, ss.157-163, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

83. Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study

Cabioglu N., Karanlik H., Muslumanoglu M., Cakmak G. K., Trablus D. C., Tukenmez M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. Abstract PS4-32: Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

CANCER RESEARCH , cilt.81, sa.4_Supplement, ss.32, 2021 (Scopus)

85. Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

86. Effect of Astragalus Membranaceus on Patients with Metastatic Non-Small Cell Lung Cancer: A Retrospective Cohort Study

Ak N., Ciftci R., Cabioglu N., Aydiner A.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, sa.2, ss.215-221, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

87. Differential expression of novel immune checkpoint receptors on tumor-infiltrating lymphocytes in patients with locally advanced breast cancer after neoadjuvant chemotherapy

Abbasov A., Aktas Cetin E., Cabioglu N., Mollavelioglu B., Onder S., Emiroglu S., et al.

NEOPLASMA , sa.5, ss.1079-1090, 2021 (SCI-Expanded, Scopus)

88. Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)

Abbasov A., ÇETİN E., CABIOĞLU N., MOLLAVELİOĞLU B., ÖNDER S., EMİROĞLU S., et al.

CANCER RESEARCH , cilt.80, sa.16, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. Poor Biological Factors and Prognosis of Interval Breast Cancers: Long-Term Results of Bahceehir (Istanbul) Breast Cancer Screening Project in Turkey

CABIOĞLU N., ÖZKAN GÜRDAL S., Kayhan A., OEzaydin N., Sahin C., Can O., et al.

JCO GLOBAL ONCOLOGY , cilt.6, ss.1103-1113, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

90. Comparison of Qualitative and Volumetric Assessments of Breast Density and Analyses of Breast Compression Parameters and Breast Volume of Women in Bahcesehir Mammography Screening Project

Gemici A. A., ARIBAL M. E., ÖZAYDIN A. N., ÖZKAN GÜRDAL S., Ozcinar B., CABIOĞLU N., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.16, sa.2, ss.110-116, 2020 (ESCI, TRDizin) Sürdürülebilir Kalkınma

91. Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer

Kizildag Yirgin İ., Has D., Arslan G., Aydin E. C., Sari M., Onder S., et al.

EUROPEAN JOURNAL OF RADIOLOGY OPEN , cilt.7, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

92. Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas

Turkyilmaz Z., Aydin T., Yilmaz R. S., Onder S., Ozkurt E., Tukenmez M., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.15, ss.171-175, 2019 (ESCI, TRDizin)

93. "Hidradenoma of the breast: Magnetic resonance (MR) imaging and ultrasonography (US) findings of this rare mass".

Yılmaz R. S., Tuncer S., Önder S., Cabıoğlu N., Acunas G.

The breast journal , cilt.25, ss.314-315, 2019 (SCI-Expanded, Scopus)

94. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy

Cabioglu N., Onder S., Oner G., Karatay H., Ozkurt E., Trablus D. C., et al.

BREAST , cilt.44, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

95. Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma

Erdogan O. S., Erciyas S., Bilir A., Tuncer S. B., Odemis D. A., Kurul S., et al.

BIOMED RESEARCH INTERNATIONAL , cilt.2019, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

96. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer

Ozkurt E., Yardımcı E., Tukenmez M., Ersoy Y. E., Yilmaz R. S., Cabioglu N., et al.

BREAST JOURNAL , cilt.25, ss.96-102, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

97. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.

Cabıoğlu N., Karanlık H., Kangal D., Ozkurt E., Öner G., Sezen F., et al.

Annals of surgical oncology , cilt.25, ss.3030-3036, 2018 (SCI-Expanded, Scopus)

98. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.25, ss.3141-3149, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

99. Favorable Long-Term Outcome in Male Breast Cancer

Ozkurt E., Tukenmez M., Yilmaz R. S., Cabioglu N., Muslumanoglu M., Dinccag A. S., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.14, ss.180-185, 2018 (ESCI, TRDizin) Sürdürülebilir Kalkınma

100. High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.

Oner G., Önder S., Karatay H., Tükenmez M., Muslumanoglu M., Igci A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up

Ozkurt E., Tukenmez M., Guven E., Ozden B. C., Oner G., Muslumanoglu M., et al.

BALKAN MEDICAL JOURNAL , cilt.35, ss.84-92, 2018 (SCI-Expanded, Scopus, TRDizin)

102. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis

Onder S., Fayda M., Karanlik H., Bayram A., Sen F., Cabioglu N., et al.

BREAST JOURNAL , cilt.23, sa.6, ss.638-646, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

103. Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahcesehir Mammography Screening Project

Ozmen V., Özkan Gürdal S., Cabioglu N., Ozcinar B., Ozaydin A. N., Kayhan A., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.13, ss.117-125, 2017 (ESCI, TRDizin) Sürdürülebilir Kalkınma

104. Radiologic findings of screen-detected cancers in an organized population-based screening mammography program in Turkey

Kayhan A., Aribal E., Sahin C., Tasci O. C., Özkan Gürdal S., Ozturk E., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.22, ss.508-513, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

105. Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey

Ozmen V., Atasoy A., Gökmen E., Ozdogan M., Guler N., Uras C., et al.

JOURNAL OF BREAST HEALTH , cilt.12, ss.107-111, 2016 (ESCI, TRDizin) Sürdürülebilir Kalkınma

106. Perforated double appendicitis: Horseshoe type

Bulut S. P., Cabioglu N., Akinci M.

TURKISH JOURNAL OF SURGERY , cilt.32, sa.2, ss.134-136, 2016 (ESCI, Scopus, TRDizin)

107. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome

Karanlik H., Özgür I., Cabioglu N., Sen F., Erturk K., Kilic B., et al.

EJSO , cilt.41, sa.9, ss.1226-1233, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. The Use of Ligasure Vessel Sealing System in Axillary Dissection; Effect on Seroma Formation

Tükenmez M., Agcaoglu O., Aksakal N., Destek S., Cabıoğlu N., Barbaros U., et al.

CHIRURGIA , cilt.109, ss.620-625, 2014 (ESCI, Scopus)

109. Successful First Round Results of a Turkish Breast Cancer Screening Program with Mammography in Bahcesehir, Istanbul

Kayhan A., Gurdal S. O., Ozaydin N., Cabioglu N., Ozturk E., Ozcinar B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, ss.1693-1697, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. Factors Predicting Microinvasion in Ductal Carcinoma in situ

Ozkan-Gurdal S., Cabioglu N., Ozcinar B., Muslumanoglu M., Ozmen V., Kecer M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, ss.55-60, 2014 (SCI-Expanded, Scopus)

111. Successful results of a population-based organized mammography screening program in a developing country: The Turkish experience

OZMEN V., OZKAN-GURDAL S., KAYHAN A., OZAYDIN N., CABIOGLU N., Ozcinar B., et al.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study (protocol MF07-01)

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

113. Molecular profiles of screen detected breast cancers: Final results of Turkish Bahcesehir breast cancer screening project

Cabioglu N., Ozkan-Gurdal S., Kayhan A., Ozaydin N., Ozcinar B., Aribal E., et al.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

114. Young-onset breast cancer exhibits a more aggressive tumor biology

CABIOĞLU N., Bozdogan A., Eren-Boler D., Kara H., Karayagiz H., Uras C.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

115. FIRST ROUND RESULTS OF A LONG TERM POPULATION- BASED BREAST CANCER SCREENING PROGRAM FROM BAHCESEHIR

Kayhan A., Gurdal S. O., ÖZAYDIN A. N., Ozturk E., CABIOĞLU N., ARIBAL M. E., et al.

JOURNAL OF BREAST HEALTH , cilt.8, sa.4, ss.180-184, 2012 (ESCI) Sürdürülebilir Kalkınma

116. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases

Boler D. E., URAS C., İNCE Ü., CABIOĞLU N.

BREAST , cilt.21, sa.4, ss.518-523, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

117. Positive or close margins in breast conserving surgery: Is re-excision always necessary?

Gurdal S. O., Karanlik H., Cabioglu N., Ozcinar B., Yavuz E., Tuzlali S., et al.

EJSO , cilt.38, sa.5, ss.399-406, 2012 (SCI-Expanded, Scopus)

118. Comparison of Intermittent Pneumatic Compression with Manual Lymphatic Drainage for Treatment of Breast Cancer-Related Lymphedema

Gurdal S. O., Kostanoglu A., Cavdar I., Ozbas A., Cabioglu N., Ozcinar B., et al.

LYMPHATIC RESEARCH AND BIOLOGY , cilt.10, sa.3, ss.129-135, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary?

Boler D. E., Cabioglu N., Ince U., Esen G., Uras C.

ISRN surgery , cilt.2012, ss.394095, 2012 (Hakemli Dergi)

120. Successfully treated Mycobacterium abscessus mastitis: A rare cause of breast masses

Yasar K. K., Pehlivanoglu F., Sengoz G., CABIOĞLU N.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY , cilt.29, sa.4, ss.425-427, 2011 (SCI-Expanded, Scopus)

121. Survey on a Mammographic Screening Program in Istanbul, Turkey

Ozmen V., ÖZAYDIN A. N., Cabioglu N., Gulluoglu B. M., Unalan P. C., Gorpe S., et al.

BREAST JOURNAL , cilt.17, sa.3, ss.260-267, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

122. A Randomized Trial Comparing Intermittent Pneumatic Compression with Manual Lymphatic Drainage for Treatment of Lymphedema in Patients with Breast Cancer

Gurdal S. O., KOSTANOGLU A., CAVDAR I., OZBAS A., CABIOGLU N., Ozcinar B., et al.

CANCER RESEARCH , cilt.70, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

123. Appendicitis with Atypical Location Owing to Malrotation: A Case Report

Ozer E., Kocakusak A., Avsar U., Akinci M., CABIOĞLU N.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.48, sa.2, ss.89-91, 2010 (ESCI, TRDizin)

124. BREAST CANCER KNOWLEDGE, SOURCE OF INFORMATION, AND BREAST HEALTH PRACTICES OF WOMEN IN BAHCESEHIR

ÖZAYDIN A. N., GÜLLÜOĞLU M. B., Unalan P. C., Gorpe S., CABIOĞLU N., Oner B. R., et al.

JOURNAL OF BREAST HEALTH , cilt.5, sa.4, ss.214-224, 2009 (ESCI) Sürdürülebilir Kalkınma

125. Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

CABIOĞLU N., Sahin A. A., Morandi P., Meric-Bernstam F., Islam R., Lin H. Y., et al.

ANNALS OF ONCOLOGY , cilt.20, sa.6, ss.1013-1019, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

126. Breast cancer risk factors in Turkish women - a University Hospital based nested case control study

Ozmen V., Ozcinar B., Karanlik H., Cabioglu N., Tukenmez M., Disci R., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.7, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

127. Increased Lymph Node Positivity in Multifocal and Multicentric Breast Cancer

Cabioglu N., Ozmen V., Kaya H., Tuzlali S., Igci A., Muslumanoglu M., et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , cilt.208, sa.1, ss.67-74, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

128. Immune changes in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy

Cabioǧlu N., Müslümanoǧlu M. E., Tütüncü Y., Adin-Cinar S., Gürel N., KIRAN B., et al.

Turkish Journal of Immunology , cilt.13, sa.1, ss.15-20, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

129. Guideline Implementation for Breast Healthcare in Low- and Middle-income Countries Early Detection Resource Allocation

Yip C., Smith R. A., Anderson B. O., Miller A. B., Thomas D. B., Ang E., et al.

CANCER , cilt.113, ss.2244-2256, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

130. Detection of bone marrow micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) in patients with early breast cancer Erken evre meme kanserinde revers transkriptaz polimeraz zincir reaksiyonu (RT-PCR) tekniǧi ile kemik iliǧi mikrometastazlarinin araştirilmasi

Cabioǧlu N., Yildirim E. O., Bitişik Ö., Yazici H., Müslümanoǧlu M., Dalay N., et al.

Turk Onkoloji Dergisi , cilt.23, sa.2, ss.55-62, 2008 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

131. Immune changes in patients with locally advenced breast cancer receiving neoadjuvant chemotherapy.

CABIOĞLU N., MÜSLÜMANOĞLU M. E., Tütüncü Y., ÇINAR S., Gürel N., Kıran B., et al.

Türk İmmünoloji Dergisi , cilt.13, ss.15-20, 2008 (Hakemli Dergi) Sürdürülebilir Kalkınma

132. TREATMENT MODALITIES OF PHYLLODES TUMORS OF THE BREAST

CABIOĞLU N., Celik T., ÖZMEN V., Igci A., Muslumanoglu M., ÖZÇINAR B., et al.

JOURNAL OF BREAST HEALTH , cilt.4, sa.2, ss.99-104, 2008 (ESCI)

133. Clinical Management of Acute Pancreatitis

CABIOĞLU N., Yanar H. T.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.46, sa.1, ss.1-14, 2008 (ESCI, Scopus, TRDizin)

134. Erken Evre Meme Kanserinde Revers Transkriptaz Polimeraz Zincir Reaksiyonu Tekniği ile Kemik İliği Mikrometastazlarının Araştırılması

CABİOĞLU N., YILDIRIM O., Bitişik Ö., YAZICI ÖZBEK H., MÜSLÜMANOĞLU M. E., DALAY M. N., et al.

TÜRK ONKOLOJİ DERGİSİ , cilt.23, sa.2, ss.55-62, 2008 (Scopus, TRDizin) Sürdürülebilir Kalkınma

135. Predictive factors for local recurrence after breast conservative surgery following neoadjuvant chemotherapy: our long-term results

CABIOĞLU N., Muslumanoglu M., Igci A., Ozcinar B., Ozmen V., Dagoglu T., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.23, sa.2, ss.81-90, 2008 (ESCI, Scopus, TRDizin)

136. Is the thymidine labeling index a good prognostic marker in breast cancer?

Sen-Oran E., Ozmen V., Bilir A., Cabioglu N., Muslumanoglu M., Igci A., et al.

World journal of surgical oncology , cilt.5, ss.93, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

137. Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer

CABIOĞLU N., Gong Y., Islam R., Broglio K. R., Sneige N., Sahin A., et al.

ANNALS OF ONCOLOGY , cilt.18, sa.6, ss.1021-1029, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

138. Manipulating the chemokine-chemokine receptor network to treat cancer

Ruffini P. A., Morandi P., CABIOĞLU N., Altundag K., Cristofanilli M.

CANCER , cilt.109, sa.12, ss.2392-2404, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

139. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery

CABIOĞLU N., Hunt K. K., Sahin A. A., Kuerer H. M., Babiera G. V., Singletary S. E., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.14, sa.4, ss.1458-1471, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

140. Primary ovarian cancer presenting with axillary lymph node metastases: A report of two cases

Ozmen V., Asoglu O., Karanlık H., Cabıoglu N., Kecer M., Bakkaloglu H.

ACTA CHIRURGICA BELGICA , cilt.107, ss.75-77, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

141. Sentinel lymph node biopsy for breast cancer: Current controversies

Ozmen V., CABIOGLU N.

BREAST JOURNAL , cilt.12, sa.5, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

142. Fournier's gangrene: Risk factors and strategies for management

Yanar H. T., Taviloglu K., Ertekin C., Guloglu R., Zorba U., Cabioglu N., et al.

WORLD JOURNAL OF SURGERY , cilt.30, sa.9, ss.1750-1754, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

143. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer

Andre F., CABIOĞLU N., Assi H., Sabourin J. C., Delaloge S., Sahin A., et al.

ANNALS OF ONCOLOGY , cilt.17, sa.6, ss.945-951, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

144. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer

Ozmen V., KARANLIK H., CABIOGLU N., IGCI A., KECER M., ASOGLU O., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.95, sa.1, ss.1-6, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

145. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T-1 breast cancer

CABIOĞLU N., Yazici M., Arun B., Broglio K., Hortobagyi G., Price J., et al.

CLINICAL CANCER RESEARCH , cilt.11, sa.16, ss.5686-5693, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

146. CXCL-12/stromal cell-derived factor-1 alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation

Cabioglu N., Summy J., Miller C., Parikh N., Sahin A., Tuzlali S., et al.

CANCER RESEARCH , cilt.65, sa.15, ss.6493-6497, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Improving local control with breast-conserving therapy - A 27-year single-institution experience

CABIOĞLU N., Hunt K., Buchholz T., Mirza N., Singletary S., Kuerer H., et al.

CANCER , cilt.104, sa.1, ss.20-29, 2005 (SCI-Expanded, Scopus)

148. Idiopathic necrotizing fasciitis: Risk factors and strategies for management

Taviloglu K., Cabioglu N., Cagatay A., Yanar H. T., Ertekin C., Baspinar I., et al.

AMERICAN SURGEON , sa.4, ss.315-320, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

149. Feasibility of surgical management in patients with granulomatous mastitis

Asoglu O., Ozmen V., Karanlık H., Tunacı M., Cabıoglu N., Igcı A., et al.

BREAST JOURNAL , cilt.11, ss.108-114, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

150. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

CABIOGLU N., SAHIN A., DOUCET M., YAVUZ E., IGCI A., YILDIRIM E., et al.

CLINICAL & EXPERIMENTAL METASTASIS , cilt.22, sa.1, ss.39-46, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

151. SHARK CARTILAGE IMPROVES SURVIVAL IN TUMOR IMPLANTED MICE

Kiran B., Zeybek U., Lama A., Cabioglu N., Deniz G.

ANTICANCER RESEARCH , cilt.24, ss.3536, 2004 (SCI-Expanded, Scopus)

152. Thymidine labeling index: Prognostic role in breast cancer

Bilir A., Eralp Y., Cabioglu N., Agizhali B., Camlica H., Aydiner A.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.27, sa.4, ss.400-406, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

153. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge

CABIOĞLU N., Krishnamurthy S., Kuerer H., Hunt K., Singletary S., Meric-Bernstam F., et al.

CANCER , cilt.101, sa.3, ss.508-517, 2004 (SCI-Expanded, Scopus)

154. T-cell lymphoblastic lymphoma presenting with a breast mass

Yumuk P., Aydiner A., Topuz E., Cabioglu N., Dogan O.

LEUKEMIA & LYMPHOMA , cilt.45, sa.4, ss.833-836, 2004 (SCI-Expanded, Scopus)

155. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge

CABIOĞLU N., Hunt K., Singletary S., Stephens T., Marcy S., Meric F., et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , cilt.196, sa.3, ss.354-364, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

156. Inflammatory breast cancer: Results of antracycline-based neoadjuvant chemotherapy

Ozmen V., Cabioglu N., Igci A., Dagoglu T., AYDINER A., Kecer M., et al.

Breast Journal , cilt.9, sa.2, ss.79-85, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

157. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer

Ozmen V., MUSLUMANOGLU M. E., CABIOGLU N., TUZLALI S., ILHAN R., IGCI A., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.76, sa.3, ss.237-244, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

158. An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer

Cabioglu V., Igci A., Yildirim E., Aktas E., Bilgic S., Yavuz E., et al.

AMERICAN JOURNAL OF SURGERY , sa.5, ss.414-417, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

159. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis.

Cabioglu N., Bilgic S., Deniz G., Aktas E., Seyhun Y., Turna A., et al.

Archives of surgery (Chicago, Ill. : 1960) , cilt.137, sa.9, 2002 (SCI-Expanded, Scopus)

160. Endoscopic sphincterotomy in the management of postoperative biliary fistula

Dolay K., Akcakaya A., Soybir G., Cabioglu N., Muslumanoglu M., Igci A., et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , cilt.16, sa.6, ss.985-988, 2002 (SCI-Expanded, Scopus)

161. Endoscopic ligation for patients with active bleeding Mallory-Weiss tears

Gunay K., Cabioglu N., Barbaros U., Taviloglu K., Ertekin C.

SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES , cilt.15, sa.11, ss.1305-1307, 2001 (SCI-Expanded, Scopus)

162. Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome

Ozmen V., CABIOGLU N., DOLAY K., BILIR A., KECER M., AYDINER A., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.68, sa.2, ss.147-157, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

163. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients

Yazici H., BITISIK O., AKISIK E., CABIOGLU N., SAIP P. M., MUSLUMANOGLU M. E., et al.

BRITISH JOURNAL OF CANCER , cilt.83, sa.6, ss.737-742, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

164. Alterations in cellular immunity of normal pregnant women: Increased percentages of peripheral large granular lymphocytes during early pregnancy

Akgul C., Cabioglu N., Gurel N., Ibrahimoglu L., Altug T., Deniz G.

Turkish Journal of Immunology , cilt.3, sa.1, ss.31-36, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 122

1. MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET/AGO-B-062; NCT05559411)

Banys-Paluchowski M., Ditsch N., Ryu J. M., Cabioglu N., Cakmak G. K., Tvedskov T. F., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)

2. TRİPLE-NEGATİF MEME KANSERİNDE MIF/CD74 EKSENİNİN TÜMÖR DERECESİ İLE İLİŞKİSİ VE İMMÜN PROFİL ANALİZİ.

Kökoğlu A., ÇETİN E., CABIOĞLU N., MOLLAVELİOĞLU B., EMİROĞLU S., ÖNDER S., et al.

XXVII. Ulusal İmmünoloji Kongresi, Bursa, Türkiye, 26 Nisan 2026, ss.70, (Özet Bildiri)

3. AİLE ÖYKÜSÜ POZİTİF MEME KANSERLİ HASTALARDA NÜKS ORANI TOPLUM SIKLIĞINDAN YÜKSEK MİDİR?

Erdönmez Çelik A. H., Mollavelioğlu B., Emiroğlu S., Tükenmez M., Cabıoğlu N., Müslümanoğlu M. E.

18. Ulusal Meme Hastalıkları Kongresi, Girne, Kıbrıs (Kktc), 27 - 30 Kasım 2025, (Yayınlanmadı)

4. Erken Evre Meme Kanserinde Perkütan Kriyoablasyon: İlk Deneyim ve Erken Dönem Sonuçlar

Kızıldağ Yırgın İ., Çelik L., Cömert Bozkurt R. G., Kılıç B., Yılmaz C., İbiş K., et al.

18. Ulusal Meme Hastalıkları Kongresi, İskele, Kıbrıs (Kktc), 27 - 30 Kasım 2025, ss.96-99, (Özet Bildiri)

5. Neoadjuvan tedavi sonrası yüksek volümlü aksiller rezidüel hastalığı olan hastalarda lokal kontrolde aksiller diseksiyon gerekli midir?

Müslümanoğlu M., Mollavelioğlu B., Can B., Bağbudar S., Cömert Bozkurt R. G., Ahmed M. A., et al.

18. Ulusal Meme Hastalıkları Kongresi, İskele, Kıbrıs (Kktc), 27 - 30 Kasım 2025, ss.178-180, (Özet Bildiri)

6. Subkutan Mastektomi ve Eş Zamanlı Rekonstrüksiyon Güvenilir Bir Yöntemdir

Emiroğlu S., Aktı N. E., Mollavelioğlu B., Kozanoğlu E., Tükenmez M., Cabıoğlu N., et al.

18. ULUSAL MEME HASTALIKLARI KONGRESİ, Gazimagusa, Kıbrıs (Kktc), 27 - 30 Kasım 2025, (Yayınlanmadı)

7. Analysis of CD74 and IFN-γ expression in peripheral blood and tumor-infiltrating lymphocytes of TNBC patients. IUIS

Kökoğlu A., ÇETİN E., CABIOĞLU N., MOLLAVELİOĞLU B., EMİROĞLU S., ÖNDER S., et al.

19th IUIS International Congress of Immunology, Viyena, Avusturya, 17 Ağustos 2025, (Tam Metin Bildiri)

8. One-Year Patient Reported Outcomes and Lymphedema in Node-Positive Breast Cancer in the Prospective Multicenter Neosenti-Turk/MF-18-03 study: Is there any benefit of Targeted Axillary Dissection over Sentinel Lymph Node Biopsy?

CABIOĞLU N., GÜL KILIÇ H., KAMALI POLAT A., USLU Y., Kılıç B., Bozdoğan A., et al.

26th Annual Meeting of the American-Society-of-Breast-Surgeons (ASBrS), Las vegas, Amerika Birleşik Devletleri, 30 Nisan 2025, cilt.32, ss.579-580, (Özet Bildiri) Sürdürülebilir Kalkınma

9. PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

CABIOĞLU N., GÜL KILIÇ H., Bozdoğan A., Rumisa Kılıç B., USLU Y., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, New York, Amerika Birleşik Devletleri, 10 Aralık 2024, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Memenın Fıbroepıtelyal Tümörlerının Ayırıcı Tanısında CD44, TERT VE KI-67’nın Yeri

KOLİK A. K., BAĞBUDAR S., BAYRAM A., KARANLIK H., CABIOĞLU N., ÖNDER S.

33. ULUSAL PATOLOJİ KONGRESİ, Türkiye, 12 - 16 Kasım 2024, (Özet Bildiri)

11. Contribution of 18F-FDG MAMMI-PET Imaging in Breast Cancer Staging

ASLANER K., HAS ŞİMŞEK D., ARSLAN D. F., YILMAZ R., ÖNDER S., CABIOĞLU N., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

12. MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET)

Banys-Paluchowski M., Kuehn T., Masannat Y., Ditsch N., Cabioglu N., Harvey J., et al.

Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)